Antidote Health, which develops a telehealth platform for the U.S. market, announced on Tuesday the completion of a $22 million Series A funding round, CTech reports. The round was led by third-time investor iAngels, Group 11, and Flint Capital.
Antidote has raised a total of $34 million to date, receiving $12 million in its Seed round last August.Antidote aims to provide tens of millions of uninsured and underinsured Americans with a virtual HMO via Artificial Intelligence that connects users to doctors with a smart chatbot and through video calls. Read more.
